1
FORM 10-Q
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the quarterly period ended JUNE 30, 1999
---------------------------------------------
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from _____________________ to_________________________
Commission File number 1-8923
HEALTH CARE REIT, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 34-1096634
- ------------------------------ -------------------
(State or jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
One SeaGate, Suite 1500, Toledo, Ohio 43604
- ------------------------------------- ---------
(Address of principal executive office) (Zip Code)
(Registrant's telephone number, including area code) (419) 247-2800
----------------------------
- --------------------------------------------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes X . No .
-------- ------
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:
Indicate by check mark whether the registrant has filed all documents and
reports required to be filed by Sections 12, 13 or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a plan
confirmed by a court. Yes _____. No _____.
APPLICABLE ONLY TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of August 4, 1999.
Class: Shares of Common Stock, $1.00 par value
Outstanding 28,376,566 shares
2
HEALTH CARE REIT, INC.
INDEX
Page
----
Part I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
Consolidated Balance Sheets - June 30, 1999
and December 31, 1998 3
Consolidated Statements of Income - Three
and six months ended June 30, 1999 and 1998 4
Consolidated Statements of Shareholders'
Equity - Six months ended June 30, 1999
and 1998 5
Consolidated Statements of Cash Flows -
Six months ended June 30, 1999 and 1998 6
Notes to Unaudited Consolidated Financial Statements 7
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations 10
Item 3. Quantitative and Qualitative Disclosure About Market Risk 13
Part II. OTHER INFORMATION
Item 4. Submission of Matters to a Vote of Security Holders 14
Item 5. Other Information 14
Item 6. Exhibits and Reports on Form 8-K 15
SIGNATURES 16
EXHIBIT INDEX 17
-2-
3
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
--------------------
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
HEALTH CARE REIT, INC. AND SUBSIDIARIES
JUNE 30 DECEMBER 31
1999 1998
(UNAUDITED) (NOTE)
----------- -----------
(IN THOUSANDS)
ASSETS
Real estate investments:
Real property owned:
Land $ 60,847 $ 44,722
Buildings & improvements 636,149 443,574
Construction in progress 100,794 151,317
----------- -----------
797,790 639,613
Less accumulated depreciation (27,505) (19,624)
----------- -----------
Total real property owned 770,285 619,989
Loans receivable 421,612 405,963
Direct financing leases 1,108 6,741
----------- -----------
1,193,005 1,032,693
Less allowance for loan losses (5,287) (4,987)
----------- -----------
Net real estate investments 1,187,718 1,027,706
Other Assets:
Direct investments 27,654 26,180
Marketable securities 1,504 4,106
Cash and cash equivalents 907 1,269
Deferred loan expenses 3,575 2,389
Receivables and other assets 14,155 11,774
----------- -----------
47,795 45,718
----------- -----------
TOTAL ASSETS $ 1,235,513 $ 1,073,424
=========== ===========
LIABILITIES AND SHAREHOLDERS' EQUITY
Liabilities:
Borrowings under line of credit obligations $ 156,600 $ 171,550
Senior unsecured notes 290,000 240,000
Secured debt 57,386 7,429
Accrued expenses and other liabilities 24,175 20,686
----------- -----------
TOTAL LIABILITIES 528,161 439,665
Shareholders' equity:
Preferred Stock, $1.00 par value:
Authorized - 10,000,000 shares
Issued and outstanding - 6,000,000 in 1999
and 3,000,000 in 1998 150,000 75,000
Common Stock, $1.00 par value:
Authorized - 75,000,000 shares
Issued and outstanding - 28,378,791
in 1999 and 28,240,025 in 1998 28,379 28,240
Capital in excess of par value 521,362 520,692
Undistributed net income 10,621 10,434
Accumulated other
comprehensive income 1,213 3,982
Unamortized restricted stock (4,223) (4,589)
----------- -----------
TOTAL SHAREHOLDERS' EQUITY 707,352 633,759
----------- -----------
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 1,235,513 $ 1,073,424
=========== ===========
NOTE: The balance sheet at December 31, 1998 has been derived from the audited
financial statements at that date but does not include all of the information
and footnotes required by generally accepted accounting principles for complete
financial statements.
See notes to unaudited consolidated financial statements
-3-
4
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
HEALTH CARE REIT, INC. AND SUBSIDIARIES
THREE MONTHS ENDED SIX MONTHS ENDED
JUNE 30 JUNE 30
1999 1998 1999 1998
----------------- -----------------
(IN THOUSANDS EXCEPT PER SHARE DATA)
REVENUES:
Rental income $18,180 $ 9,839 $32,420 $17,697
Interest income 12,142 11,831 23,937 23,947
Commitment fees and other income 1,672 1,489 3,618 2,741
Prepayment fees 475 0 658 0
------- ------- ------- -------
Total revenue $32,469 $23,159 $60,633 $44,385
EXPENSES:
Interest expense $ 6,680 $ 4,461 $10,949 $ 8,701
Loan expense 252 181 418 357
Provision for depreciation 4,451 2,292 8,006 4,162
Provision for losses 150 150 300 300
General and administrative expenses 1,872 1,336 3,546 2,717
------- ------- ------- -------
Total expenses $13,405 $ 8,420 $23,219 $16,237
------- ------- ------- -------
Net income before gain on sale of
properties $19,064 $14,739 $37,414 $28,148
Gain on sale of properties 75 0 703 0
------- ------- ------- -------
Net Income 19,139 14,739 38,117 28,148
Preferred stock dividends 3,352 832 6,111 832
------- ------- ------- -------
Net Income Available to
Common Shareholders $15,787 $13,907 $32,006 $27,316
======= ======= ======= =======
Average number of common shares
outstanding:
Basic 28,145 25,272 28,111 25,768
Diluted 28,440 25,612 28,431 25,130
Net income per share:
Basic $ 0.56 $ 0.55 $ 1.14 $ 1.10
Diluted 0.56 0.54 1.13 1.09
Dividends declared and paid per
common share $ 0.565 $ 0.545 $ 1.125 $ 1.085
See notes to unaudited consolidated financial statements
-4-
5
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)
HEALTH CARE REIT, INC. AND SUBSIDIARIES
Six months ended June 30, 1999
----------------------------------------------------------------------------------------
Capital In Unamortized Accum. Other
Preferred Common Excess Of Restricted Undistributed Comprehensive
In thousands Stock Stock Par Value Stock Net Income Income Total
----------------------------------------------------------------------------------------
Balance at beginning of period $ 75,000 28,240 $ 520,692 $ (4,589) $ 10,434 $ 3,982 $ 633,759
Comprehensive income:
Net income 38,117 38,117
Unrealized gains on securities (2,602) (2,602)
Foreign currency translation adjustment (167) (167)
---------
Comprehensive income 37,950
---------
Proceeds from issuance of shares
from dividend reinvestment plan and 139 3,125 (228) 3,036
stock incentive plans
Proceeds from sale of Preferred Stock 75,000 (2,455) 72,545
Amortization of restricted stock grants 594 594
Cash dividends paid (37,930) (37,930)
--------- -------- --------- -------- -------- ------- ---------
Balance at end of period $ 150,000 $ 28,379 $ 521,362 $ (4,223) $ 10,621 $ 1,213 $ 707,352
========= ======== ========= ======== ======== ======= =========
Six months ended June 30, 1998
----------------------------------------------------------------------------------------
Capital In Unamortized Accum. Other
Preferred Common Excess Of Restricted Undistributed Comprehensive
Stock Stock Par Value Stock Net Income Income Total
----------------------------------------------------------------------------------------
Balance at beginning of period $ $ 24,341 $ 435,603 $ (3,532) $ 8,841 $ 4,671 $ 469,924
Comprehensive income:
Net income 28,148 28,148
Unrealized gains on securities (838) (838)
Foreign currency translation adjustment (189) (189)
Comprehensive income 27,121
---------
Proceeds from issuance of shares
from dividend reinvestment plan and 203 4,766 (64) 4,905
stock incentive plans
Proceeds from sale of shares 913 22,808 23,721
Proceeds from sale of Preferred Stock 75,000 (2,477) 72,523
Amortization of restricted stock grants 230 230
Cash dividends paid (27,817) (27,817)
-------- -------- --------- -------- -------- ------- ---------
Balance at end of period $ 75,000 $ 25,457 $ 460,700 $ (3,366) $ 9,172 $ 3,644 $ 570,607
======== ======== ========= ======== ======== ======= =========
See notes to unaudited consolidated financial statements
-5-
6
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
HEALTH CARE REIT, INC. AND SUBSIDIARIES
SIX MONTHS ENDED
JUNE 30
1999 1998
----------------------
(IN THOUSANDS)
OPERATING ACTIVITIES
Net income $ 38,117 $ 28,148
Adjustments to reconcile net income to net cash
Provision for depreciation 8,107 4,198
Provision for losses 300 300
Amortization 1,012 588
Loan and commitment fees earned less than cash received 1,001 523
Direct financing lease income less than cash received 65 213
Rental income in excess of cash received (3,138) (569)
Interest and other income in excess of cash received (138) (164)
Increase in accrued expenses and other liabilities 2,487 3,459
Decrease in receivables and other assets 982 695
--------- ---------
NET CASH PROVIDED FROM OPERATING ACTIVITIES 48,795 37,391
INVESTING ACTIVITIES
Investment in real properties (158,558) (129,768)
Investment in loans receivable (37,211) (62,980)
Other investments (3,822) (16,856)
Principal collected on loans 21,561 11,605
Proceeds from sale of properties 8,142
Other (325) (169)
--------- ---------
NET CASH USED IN INVESTING ACTIVITIES (170,213) (198,167)
FINANCING ACTIVITIES
Net payments under line of credit arrangements (14,950) (11,200)
Principal payments on long-term obligations (43) (23,203)
Net proceeds from the issuance of Common Stock 2,859 28,625
Net proceeds from the issuance of Preferred Stock 72,545 72,523
Proceeds from issuance of Senior Notes 50,000 100,000
Proceeds from issuance of Secured Debt 50,000
Increase in deferred loan expense (1,427) (663)
Cash distributions to shareholders (37,928) (27,817)
--------- ---------
NET CASH PROVIDED FROM FINANCING ACTIVITIES 121,056 160,665
--------- ---------
Decrease in cash and cash equivalents (362) (111)
Cash and cash equivalents at beginning of period 1,269 1,381
--------- ---------
CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 907 $ 1,270
========= =========
Supplemental Cash Flow Information -- Interest Paid $ 15,353 $ 10,155
========= =========
See notes to unaudited consolidated financial statements
-6-
7
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
HEALTH CARE REIT, INC. AND SUBSIDIARIES
NOTE A - BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements have been prepared
in accordance with generally accepted accounting principles for interim
financial information and with instructions to Form 10-Q and Article 10 of
Regulation S-X. Accordingly, they do not include all the information and
footnotes required by generally accepted accounting principles for complete
financial statements. In the opinion of management, all adjustments (consisting
of normal recurring accruals) considered for a fair presentation have been
included. Operating results for the three months ended June 30, 1999, are not
necessarily an indication of the results that may be expected for the year
ending December 31, 1999. For further information, refer to the financial
statements and footnotes thereto included in the Company's annual report on Form
10-K for the year ended December 31, 1998.
NOTE B - REAL ESTATE INVESTMENTS
During the six months ended June 30, 1999, the Company invested $74,322,000 in
real property, made construction advances of $107,623,000, provided permanent
mortgage financings of $12,511,000, and funded $4,750,000 of equity related
investments. During the six months ended June 30, 1999, the Company received
principal payments on real estate mortgages of $21,561,000 and had net advances
on working capital loans of $1,313,000.
With respect to the above-mentioned construction advances, funding for
construction in progress in connection with 50 properties owned directly by the
Company totaled $84,236,000, and funding associated with 14 construction loans
represented $23,387,000. During the six months ended June 30, 1999, 19 of the
construction properties in progress completed the construction phase of the
Company's investment process and were converted to permanent operating leases,
with an aggregate investment balance of $134,759,000. Also, during the six
months ended June 30, 1999, six of the construction loans completed the
construction phase of the Company's investment process and were converted to
investments in permanent mortgage loans, with an aggregate investment of
$41,222,000.
NOTE C - INDEBTEDNESS
In February 1999, the Company entered into a $50,000,000 Secured Credit
Agreement. The Credit Agreement bears interest at the lender's prime rate or
LIBOR plus 2.0%, with a floor interest rate of 7.0%. At June 30, 1999,
$50,000,000 was advanced under this Credit Agreement.
In March 1999, the Company completed the sale of $50 million of 8.17% Senior
Unsecured Notes due March 15, 2006.
The Company has a total of $190,000,000 in unsecured credit facilities bearing
interest at the lenders' prime rate or LIBOR plus 1.0%. A total of approximately
$33,400,000 was available at June 30, 1999, subject to compliance with the terms
and conditions of the unsecured credit facilities.
-7-
8
NOTE D - SHAREHOLDERS' EQUITY
In January 1999, the Company announced the sale of 3,000,000 shares of
cumulative convertible preferred stock. These shares have a liquidation value of
$25.00 per share and will pay dividends equivalent to the greater of (i) the
annual dividend rate of $2.25 per share (a quarterly dividend rate of $0.5625
per share); or (ii) the quarterly dividend then payable per common share on an
as converted basis. The preferred shares are convertible into common stock at a
conversion price of $25.625 per share. The Company has the right to redeem the
preferred shares after five years.
In May 1998, the Company sold 3,000,000 shares of 8.875% Series B Cumulative
Redeemable Preferred Stock with a liquidation preference of $25.00 per share. On
and after May 1, 2003, the Preferred Stock may be redeemed for cash at the
option of the Company, in whole or in part, at $25.00 per share, plus accrued
and unpaid dividends thereon to the redemption date.
NOTE E - DIRECT INVESTMENTS
Management determines the appropriate classification of a direct investment at
the time of acquisition and reevaluates such designation as of each balance
sheet date. Debt securities which are classified as held to maturity are stated
at historical cost. Equity investments are stated at historical cost. At June
30, 1999, direct investments included the preferred stock of one private
corporation and subordinated debt in eight private corporations, and ownership
representing a 31% interest in Atlantic Healthcare Finance L.P., a property
investment group that specializes in the financing, through sale and leaseback
transactions, of nursing homes located in the United Kingdom and continental
Europe.
NOTE F - MARKETABLE SECURITIES
Marketable securities are stated at market value with unrealized gains and
losses reported in a separate component of shareholders' equity. At June 30,
1999, marketable securities reflected the market value of the common stock of
two publicly owned corporations, which were obtained by the Company at no cost,
and the fair value of the common stock related to warrants in one publicly owned
corporation in excess of the exercise price.
NOTE G - CONTINGENT LIABILITIES
As disclosed in the financial statements for the year ended December 31, 1998,
the Company was contingently liable for certain obligations amounting to
$9,365,000. At June 30, 1999, the contingent obligations totaled $8,925,000.
NOTE H - DISTRIBUTIONS PAID TO COMMON SHAREHOLDERS
On February 22, 1999, the Company paid a dividend of $0.56 per share to
shareholders of record on February 2, 1999. This dividend related to the period
from October 1, 1998 through December 31, 1998.
On May 20, 1999, the Company paid a dividend of $0.565 per share to shareholders
of record on May 4, 1999. This dividend related to the period from January 1,
1999 to March 31, 1999.
-8-
9
NOTE I - EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per
share (in thousands, except per share data):
Six months ended June 30
------------------------
1999 1998
---------- -----------
Numerator for basic and diluted earnings per
share-income available to common shareholders $ 32,006 $ 27,316
======== ========
Denominator for basic earnings per share -
weighted average shares 28,111 24,768
Effect of dilutive securities:
Employee stock options 120 219
Nonvested restricted shares 200 143
-------- --------
Dilutive potential common shares 320 362
-------- --------
Denominator for diluted earnings per share -
adjusted weighted average shares 28,431 25,130
======== ========
Basic earnings per share $ 1.14 $ 1.10
Diluted earnings per share $ 1.13 $ 1.09
-9-
10
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
-------------------------------------------------
CONDITION AND RESULTS OF OPERATIONS
-----------------------------------
LIQUIDITY AND CAPITAL RESOURCES
At June 30, 1999, the Company's net real estate investments totaled
approximately $1,187,718,000 which included 166 assisted living facilities, 50
skilled nursing facilities, 15 retirement centers, six specialty care facilities
and two behavioral care facilities. The Company anticipates making additional
investments in health care related facilities. New investments are funded from
temporary borrowings under the Company's line of credit arrangements. Permanent
financing for future investments, which replaces funds drawn under the line of
credit arrangements, is expected to be provided through a combination of private
and public offerings of debt and equity securities, and the assumption of
secured debt. The Company believes its liquidity and various sources of
available capital are sufficient to fund operations, meet debt service and
dividend requirements, and finance future investments.
As of June 30, 1999, the Company had shareholders' equity of $707,352,000 and a
total outstanding debt balance of $503,986,000 which represents a debt to equity
ratio of .71 to 1.0.
In January 1999, the Company announced the sale of 3,000,000 shares of
cumulative convertible preferred stock. These shares have a liquidation value of
$25.00 per share and will pay quarterly dividends equivalent to the greater of
$0.5625 or the quarterly dividend then payable per common share on an as
converted basis. The preferred shares are convertible into common stock at a
conversion price of $25.625 per share. The Company has the right to redeem the
preferred shares after five years.
In February 1999, the Company entered into a $50,000,000 Secured Credit
Facility. The Credit Facility bears interest at the lender's prime rate or LIBOR
plus 2.0%, with a floor of 7.0%. At June 30, 1999, $50,000,000 was advanced
under this Credit Agreement.
In March 1999, the Company completed the sale of $50 million of 8.17% Senior
Unsecured Notes due March 15, 2006.
During the six months ended June 30, 1999, the proceeds derived from the
Company's capital raising activities were used to invest in additional health
care properties and reduce bank debt under the Company's revolving lines of
credit arrangements.
As of June 30, 1999, the Company has effective shelf registrations on file with
the Securities and Exchange Commission under which the Company may issue up to
$330,319,000 of securities including debt, convertible debt, common and
preferred stock. The Company anticipates issuing securities under such shelf
registrations to invest in additional health care facilities and to repay
borrowings under the Company's line of credit arrangements.
As of June 30, 1999, the Company had approximately $195,225,000 in unfunded
commitments. Under the Company's line of credit arrangements, available funding
totaled $33,400,000, subject to compliance with the terms and conditions of the
line of credit arrangements.
RESULTS OF OPERATIONS
Revenues for the three months ended June 30, 1999, were $32,469,000 as compared
with $23,159,000 for the three months ended June 30, 1998. Revenue growth was
generated primarily by increased rental income of $8,341,000 as a result of
additional real estate investments made during the past twelve months.
Revenues for the six months ended June 30, 1999 were $60,633,000 as compared
with $44,385,000 for the six months ended June 30, 1998, an increase of
$16,248,000 or 37%. Revenue growth resulted primarily from increased operating
lease income of $14,723,000, and increased loan commitment fees of $634,000 as a
result of additional real estate investments made during the past twelve months.
-10-
11
In addition, the Company recognized gains on sales of properties and prepayment
fees of $550,000 and $1,361,000 for the three and six months ended June 30,
1999, respectively. There were no such gains on sales of properties or
prepayment fees in the similar periods in 1998.
Expenses for the three months ended June 30, 1999 totaled $13,405,000, an
increase of $4,985,000 from expenses of $8,420,000 for the same period in 1998.
Expenses for the six months ended June 30, 1999 totaled $23,219,000, an increase
of $6,982,000 from expenses of $16,237,000 for the same period in 1998. The
increases in total expenses for the three and six month periods ended June 30,
1999 were related to an increase in interest expense, an additional expense
associated with the provision for depreciation and an increase in general and
administrative expenses.
Interest expense for the three months ended June 30, 1999 was $6,680,000 as
compared to $4,461,000 for the same period in 1998. For the six month period
ended June 30, 1999, interest expense totaled $10,949,000 as compared to
$8,701,000 for the same period in 1998. The increase in the 1999 period was
primarily due to the issuance of $50,000,000 Senior Notes in March, 1999 and the
issuance of $100,000,000 Senior Notes in March, 1998. The increases in the 1999
periods were offset by the amount of capitalized interest recorded during the
first six months of 1999.
The Company capitalizes certain interest costs associated with funds used to
finance the construction of properties owned directly by the Company. The amount
capitalized is based upon the borrowings outstanding during the construction
period using the rate of interest which approximates the Company's cost of
financing. The Company's interest expense is reduced by the amount capitalized.
Capitalized interest for the three and six month periods in 1999 totaled
$1,982,000, and $5,141,000, respectively, as compared with $1,617,000 and
$2,843,000 for the same periods in 1998.
The provision for depreciation for the three and six month periods ended June
30, 1999 totaled $4,451,000 and $8,006,000, respectively, increases of
$2,159,000 and $3,844,000 over the comparable periods in 1998 as a result of
additional investments in properties owned directly by the Company.
General and administrative expenses for the three and six month periods ended
June 30, 1999 totaled $1,872,000 and $3,546,000, respectively, as compared with
$1,336,000 and $2,717,000 for the same periods in 1998. The expenses for the
three and six month periods in 1999 were 5.75% and 5.78% of revenues as compared
with 5.77% and 6.12% for the same periods in 1998.
Dividend expense, associated with the Company's outstanding preferred stock, for
the three and six month periods ended June 30, 1999 totaled $3,352,000 and
$6,111,000, respectively, as compared with $832,000 for the same periods in
1998.
As a result of the various factors mentioned above, net income available to
common shareholders for the three and six month periods ended June 30, 1999 was
$15,787,000, or $0.56 per diluted share, and $32,006,000, or $1.13 per diluted
share, respectively, as compared with $13,907,000, or $0.54 per diluted share,
and $27,316,000, or $1.09 per diluted share for the comparable periods in 1998.
IMPACT OF INFLATION
During the past three years, inflation has not significantly affected the
earnings of the Company because of the moderate inflation rate. Additionally,
earnings of the Company reflect long-term investments with fixed rents or
interest rates. These investments are mainly financed with a combination of
equity, senior notes and borrowings under the revolving lines of credit. During
inflationary periods, which generally are accompanied by rising interest rates,
the Company's ability to grow may be adversely affected because the yield on new
investments may increase at a slower rate than new borrowing costs. Presuming
the current inflation rate remains moderate and long-term interest rates do not
increase significantly, the Company believes that equity and debt financing will
continue to be available.
-11-
12
YEAR 2000 COMPLIANCE
The Year 2000 compliance issue concerns the inability of certain systems and
devices to properly use or store dates beyond December 31, 1999. This could
result in system failures, malfunctions, or miscalculations that disrupt normal
operations. This issue affects most companies and organizations to large and
small degrees, at least to the extent that potential exposures must be
evaluated.
The Company believes its own internal operations, technology infrastructure,
information systems and software applications are Year 2000 compliant. The
Company is reviewing the impact of outside vendors and tenants/borrowers. The
Company initially focused this review on mission-critical operations,
recognizing that other potential effects are expected to be less material. In
those cases where there are external compliance issues, these are considered to
be minor in nature. Expenditures for any remedies will not be material.
With respect to the Company's tenants, borrowers and properties, the Company is
assessing the tenants' and borrowers' compliance efforts, the possibility of any
interface difficulties or electromechanical problems relating to compliance by
material vendors, the effects of potential non-compliance, and remedies that may
mitigate or obviate such effects. The Company plans to process information from
tenant surveys and complete its assessment by September 30, 1999.
Because the Company's evaluation of these issues has been conducted by its own
personnel or by selected inquiries of its vendors and tenants in connection with
their routine servicing operations, the Company believes that its expenditures
for assessing Year 2000 issues, though difficult to quantify, have not been
material. In addition, the Company is not aware of any issues that will require
material expenditures by the Company in the future.
Based upon current information, the Company believes that the risk posed by
foreseeable Year 2000 related problems with its internal systems (including both
information and non-information systems) is minimal. Year 2000 related problems
with the Company's software applications and internal operational programs are
unlikely to cause more than minor disruptions in the Company's operations. Year
2000 related problems at certain of its third-party service providers, such as
its banks, payroll processor, and telecommunications provider is marginally
greater. Based upon current information, the Company does not believe any such
problems would have a material effect on its operations. For example, Year 2000
related problems at such third-party service providers could delay the
processing of financial transactions and the Company's payroll and could disrupt
the Company's internal and external communications.
The Company believes that the risk posed by Year 2000 related problems at its
properties or with its tenants is marginally greater. Year 2000 related problems
at certain governmental agencies and third-party payers could delay the
processing of tenant financial transactions. Based upon current information, the
Company does not believe any such problems would have a material long-term
effect on its operations. However, neither the Company nor its tenants and
borrowers can be assured that the federal and state governments upon which they
rely for Medicare and Medicaid revenue will be in compliance in a timely manner.
Year 2000 related problems with the electromechanical systems at its properties
are unlikely to cause more than minor disruptions in the Company's operations.
The Company intends to complete outstanding assessments, implement identified
remedies, continue to monitor Year 2000 issues, and develop contingency plans
if, and to the extent deemed, necessary. However, based upon current information
and barring developments, the Company does not anticipate developing any
substantive contingency plans with respect to Year 2000 issues. In addition, the
Company has no plans to seek independent verification or review of its
assessments.
While the Company believes that it will be Year 2000 compliant by December 31,
1999, there can be no assurance that the Company will be successful in
identifying and assessing all compliance issues, or that the Company's efforts
to remedy all Year 2000 compliance issues will be effective such that they will
not have a material adverse effect on the Company's business or results of
operations.
-12-
13
OTHER INFORMATION
This document and supporting schedules may contain "forward-looking" statements
as defined in the Private Securities Litigation Reform Act of 1995.
Forward-looking statements involve known and unknown risks and uncertainties,
which may cause the Company's actual results in the future to differ materially
from expected results. These risks and uncertainties include, among others,
competition in the financing of health care facilities, the availability of
capital, and regulatory and other changes in the health care sector, as
described in the Company's filings with the Securities and Exchange Commission.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES
----------------------------------------
ABOUT MARKET RISK
-----------------
The Company is exposed to various market risks, including the potential loss
arising from adverse changes in interest rates. The Company seeks to mitigate
the effects of fluctuations in interest rates by matching the term of new
investments with new long-term fixed rate borrowings to the extent possible.
The market value of the Company's long-term fixed rate borrowings is subject to
interest rate risk. Generally, the market value of fixed rate financial
instruments will decrease as interest rates rise and increase as interest rates
fall. The estimated fair value of the Company's total long-term borrowings at
June 30, 1999, was $275 million. A 1% increase in interest rates would result in
a decrease in fair value of long-term borrowings by approximately $12 million.
The Company is subject to risks associated with debt financing, including the
risk that existing indebtedness may not be refinanced or that the terms of such
refinancing may not be as favorable as the terms of current indebtedness. The
majority of the Company's borrowings were completed pursuant to indentures or
contractual agreements which limit the amount of indebtedness the Company may
incur. Accordingly, in the event that the Company is unable to raise additional
equity or borrow money because of these limitations, the Company's ability to
acquire additional properties may be limited.
At June 30, 1999, the Company's variable interest rate debt exceeded its
variable interest rate assets, presenting an exposure to rising interest rates.
The Company may or may not elect to use financial derivative instruments to
hedge variable interest rate exposure. Such decisions are principally based on
the Company's policy to match its variable rate investments with comparable
borrowings, but is also based on the general trend in interest rates at the
applicable dates and the Company's perception of future volatility of interest
rate.
-13-
14
PART II. OTHER INFORMATION
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
----------------------------------------------------
The annual meeting of shareholders of Health Care REIT, Inc. was duly called and
held on April 20, 1999 in Toledo, Ohio. Proxies for the meeting were solicited
on behalf of the Company's management and Board of Directors pursuant to
Regulation 14A of the General Rules and Regulations of the Commission. There was
no solicitation in opposition to the management's nominees for election as
directors as listed in the Proxy Statement, and all such nominees were elected.
Votes were cast at the meeting upon the proposals described in the Proxy
Statement for the meeting (filed with the Commission pursuant to Regulation 14A
and incorporated herein by reference) as follows:
Proposal #1 - The election of three directors:
Nominee For Withheld
------------------------------- ------------------------- ----------------------
Willliam C. Ballard, Jr. 28,832,528 216,877
Peter J. Grua 28,816,891 232,514
R. Scott Trumbull 28,773,760 275,645
Proposal #2 - The approval of an amendment to the Company's Stock Plan for Non-Employee
Directors:
For 27,416,299
Against 1,334,547
Abstain 298,559
Proposal #3 - The ratification of the appointment of Ernst & Young LLP as independent auditors
for the fiscal year 1998:
For 28,833,012
Against 92,724
Abstain 123,669
ITEM 5. OTHER INFORMATION
-----------------
On April 13, 1999, the Company issued a press release in which it announced
first quarter investment activity of $99,293,000.
On April 20, 1999, the Company issued a press release in which it announced
record first quarter 1999 results and increase in quarterly dividend.
-14-
15
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
--------------------------------
(a) Exhibits
27 Financial Data Schedule
99.1 Press release dated April 13, 1999
99.2 Press release dated April 20, 1999
(b) Reports on Form 8-K
-15-
16
Pursuant to the requirement of the Securities and Exchange Act of 1934, the
Registrant had duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
HEALTH CARE REIT, INC.
Date: August 4, 1999 By: /S/ GEORGE L. CHAPMAN
------------------ ---------------------------
George L. Chapman,
Chairman, Chief Executive Officer, and
President
Date: August 4, 1999 By: /S/ EDWARD F. LANGE, JR.
------------------ -----------------------------
Edward F. Lange, Jr.,
Chief Financial Officer
Date: August 4 , 1999 By: /S/ MICHAEL A. CRABTREE
------------------ ---------------------------
Michael A. Crabtree,
Chief Accounting Officer
-16-
17
EXHIBIT INDEX
-------------
The following documents are included in this Form 10-Q as Exhibits:
DESIGNATION
NUMBER UNDER
ITEM 601 OF
REGULATION S-K EXHIBIT DESCRIPTION
-------------- ------------------------
27 Financial Data Schedule
99.1 Press release dated April 13, 1999
99.2 Press release dated April 20, 1999
-17-